trivalent salmonella conjugate vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 15, 2022 (NCT05525546)
Timeline
Indications
Mechanism of action
- SalmonellaImmunity, active
Salmonella immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05784701 | Phase 2 | Apr 5, 2023 | University of Maryland, Wellcome Trust |
| NCT05525546 | Phase 1 | Aug 15, 2022 | University of Maryland |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Maryland | Academic/Hospital | 2 | 2 | 2 | 2022 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1